Frazier Lifesciences Acquisition Corporation Warrant
FLACW
FLACW was delisted on the 22nd of November, 2022.
20 hedge funds and large institutions have $2.4M invested in Frazier Lifesciences Acquisition Corporation Warrant in 2021 Q1 according to their latest regulatory filings, with 20 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$310K |
| 2 |
DCM
DG Capital Management
New York
|
+$254K |
| 3 |
GL
Governors Lane
New York
|
+$197K |
| 4 |
RCM
Radcliffe Capital Management
Bala Cynwyd,
Pennsylvania
|
+$141K |
| 5 |
AC
Athanor Capital
New York
|
+$114K |
Top Sellers
FLACW Hedge Fund Activity: Q1 2021 in Review
20 of the 5,711 institutional investors tracked by Wall St. Rank reported a position in Frazier Lifesciences Acquisition Corporation Warrant (FLACW) for Q1 2021, worth a combined $2.4M.
Buyers outnumbered sellers: 20 funds opened new FLACW positions and 0 closed out — a net gain of 20 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Citadel Advisors, opening a new position worth an estimated $310K.
- 20 institutional investors held Frazier Lifesciences Acquisition Corporation Warrant (FLACW) as of Q1 2021, up from 0 in Q4 2020.
- Funds reported $2.4M of Frazier Lifesciences Acquisition Corporation Warrant stock for Q1 2021.
- 20 funds opened new Frazier Lifesciences Acquisition Corporation Warrant positions in Q1 2021 and 0 closed out, a net change of +20 holders.
- The largest Frazier Lifesciences Acquisition Corporation Warrant buyer in Q1 2021 was Citadel Advisors, an estimated $310K added.
Based on aggregated 13F filings for Q1 2021.